secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001493152-26-010045
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran amends preferred stock conversion rights, grants CEO 6M preferred shares
--------------------------------------------------------------------------------

- Amendment requires both Board and majority of Preferred holders to approve any conversion of Convertible Preferred Stock into common shares.
- Filing effective Feb 18, 2026 with Nevada Secretary of State.
- CEO David Platt granted 6,000,000 shares of Convertible Preferred Stock as performance-based equity award.
- Grant tied to execution of first commercial distribution agreement and capital funding initiatives.
- Aligns executive incentives with commercialization and capital formation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000149315226010045/0001493152-26-010045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000149315226010045/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-010045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer